MediGain CEO, Greg Hackney, Named ASC Industry Leader To Know
Plano, TX (PRWEB) February 26, 2014 -- Greg Hackney, the CEO of MediGain, has been named an "ASC Industry Leader to Know" by Becker's ASC Review
Hackney is responsible for planning the company's strategic direction and leading the sales, marketing and financial direction. During his more than 15 years in the industry, Mr. Hackney has experience leading companies from inception to acquisition.
He previously served as CEO of Superior Global and founded Expresiv Technologies, a healthcare speech understanding and data extraction company that was later acquired by 3M. His additional accomplishments include serving as founder, executive and consultant to many successful companies.
'I am honored to be named to Becker's ASC Industry Leader to Know list," said Hackney. "We are experiencing significant growth in our ASC Billing Division because we are able to increase the reimbursement revenue for our clients around the country."
In addition to his role at MediGain, Mr. Hackney is the managing director of Chiron Point Investment Fund and serves on the board of Ambient Health Intelligence. He earned his BS in business administration from the University of Texas in Austin.
MediGain's ASC Billing Division, headquartered in the Phoenix, AZ area, serves ambulatory surgery centers across the nation. For more information on MediGain's ASC Billing Division please go to http://www.medigain.com/ascbill.
About MediGain Services, Inc.
MediGain is a global full-service revenue cycle management and healthcare analytics company devoted to improving billing, collections, and outcomes for healthcare providers and the patients they serve. With over 400 employees, MediGain provides solutions for physician groups, provider networks, ambulatory surgery centers and hospitals enabling them to reach their maximum potential through improved operational, financial, and clinical outcomes.
Clint Hughes, MediGain, http://www.MediGain.com, +1 (972) 675-7354, [email protected]
Share this article